INTELLIGENT BIO SOLUTIONS INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that INTELLIGENT BIO SOLUTIONS INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jun 30, 2021 | $1.98M | Sep 16, 2021 |
| FY2021 | Jun 30, 2020 | $188.7K | Sep 16, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.05M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $3.11M | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $1.26M | Sep 18, 2024 |
| FY2022 | Jun 30, 2022 | $437.1K | Sep 22, 2022 |
| FY2022 | Jun 30, 2021 | $1.98M | Sep 22, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.25M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $1.43M | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $326.7K | Sep 18, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($10.57M) | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | ($10.16M) | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | ($10.63M) | Sep 18, 2024 |
| FY2023 | Jun 30, 2022 | ($8.31M) | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | ($7.04M) | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | ($3.16M) | Sep 16, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($10.64M) | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | ($10.28M) | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | ($12.60M) | Sep 18, 2024 |
| FY2023 | Jun 30, 2022 | ($8.34M) | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | ($5.57M) | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | ($2.86M) | Sep 16, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($9.68M) | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | ($9.57M) | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | ($7.38M) | Sep 18, 2024 |
| FY2023 | Jun 30, 2022 | ($3.36M) | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | ($11.30M) | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | ($498.6K) | Sep 16, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $231.8K | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $221.4K | Aug 15, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $8.25M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $13.78M | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $10.35M | Sep 18, 2024 |
| FY2023 | Jun 30, 2022 | $12.35M | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | $21.86M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $2.48M | Sep 16, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $5.44M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $5.60M | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $6.67M | Sep 18, 2024 |
| FY2023 | Jun 30, 2022 | $5.81M | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | $6.85M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $7.69M | Sep 16, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $8.33M | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $3.80M | Sep 18, 2024 |
| FY2023 | Jun 30, 2022 | $6.62M | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | $15.06M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | ($5.19M) | Sep 16, 2021 |
| FY2021 | Jun 30, 2019 | ($3.98M) | Sep 16, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | May 8, 2023 | $3.80M | Aug 23, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($62.53M) | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | ($51.96M) | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | ($41.81M) | Sep 18, 2024 |
| FY2023 | Jun 30, 2022 | ($31.18M) | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | ($22.87M) | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | ($15.83M) | Sep 16, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.02M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $6.30M | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $1.54M | Sep 18, 2024 |
| FY2023 | Jun 30, 2022 | $8.24M | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | $12.57M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $427.3K | Sep 16, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 16, 2024 | $1.65M | Aug 15, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (2) | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | (6) | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | (127) | Sep 18, 2024 |
| FY2023 | Jun 30, 2022 | (11) | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 22, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (2) | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | (6) | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | (127) | Sep 18, 2024 |
| FY2023 | Jun 30, 2022 | (11) | Aug 23, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 7.32M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | 3.46M | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | 194,200 | Sep 18, 2024 |
| FY2022 | Jun 30, 2022 | 14.89M | Sep 22, 2022 |
| FY2022 | Jun 30, 2021 | 13.58M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | 8.63M | Sep 16, 2021 |